123 related articles for article (PubMed ID: 23074300)
21. The utility of attention-deficit/hyperactivity disorder screening instruments in individuals seeking treatment for substance use disorders.
Dakwar E; Mahony A; Pavlicova M; Glass A; Brooks D; Mariani JJ; Grabowski J; Levin FR
J Clin Psychiatry; 2012 Nov; 73(11):e1372-8. PubMed ID: 23218166
[TBL] [Abstract][Full Text] [Related]
22. Utility of the Conners' Adult ADHD Rating Scale validity scales in identifying simulated attention-deficit hyperactivity disorder and random responding.
Walls BD; Wallace ER; Brothers SL; Berry DTR
Psychol Assess; 2017 Dec; 29(12):1437-1446. PubMed ID: 29227125
[TBL] [Abstract][Full Text] [Related]
23. Beck Depression Inventory-II items associated with self-reported symptoms of ADHD in adult psychiatric outpatients.
Steer RA; Ranieri WF; Kumar G; Beck AT
J Pers Assess; 2003 Feb; 80(1):58-63. PubMed ID: 12584068
[TBL] [Abstract][Full Text] [Related]
24. Examining the Rate of Self-Reported ADHD-Related Traits and Endorsement of Depression, Anxiety, Stress, and Autistic-Like Traits in Australian University Students.
Nankoo MMA; Palermo R; Bell JA; Pestell CM
J Atten Disord; 2019 Jun; 23(8):869-886. PubMed ID: 29502467
[TBL] [Abstract][Full Text] [Related]
25. Screening for attention-deficit/hyperactivity disorder in adult inpatients with psychiatric disorders.
Kumar G; Faden J; Steer RA
Psychol Rep; 2011 Jun; 108(3):815-24. PubMed ID: 21879629
[TBL] [Abstract][Full Text] [Related]
26. Intentional inattention: Detecting feigned attention-deficit/hyperactivity disorder on the Personality Assessment Inventory.
Smith ST; Cox J; Mowle EN; Edens JF
Psychol Assess; 2017 Dec; 29(12):1447-1457. PubMed ID: 29227126
[TBL] [Abstract][Full Text] [Related]
27. Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder.
Adler LA; Liebowitz M; Kronenberger W; Qiao M; Rubin R; Hollandbeck M; Deldar A; Schuh K; Durell T
Depress Anxiety; 2009; 26(3):212-21. PubMed ID: 19194995
[TBL] [Abstract][Full Text] [Related]
28. Detecting feigned ADHD in later adolescence: an examination of three PAI-A negative distortion indicators.
Rios J; Morey LC
J Pers Assess; 2013; 95(6):594-9. PubMed ID: 23924156
[TBL] [Abstract][Full Text] [Related]
29. The reliability and validity of self- and investigator ratings of ADHD in adults.
Adler LA; Faraone SV; Spencer TJ; Michelson D; Reimherr FW; Glatt SJ; Marchant BK; Biederman J
J Atten Disord; 2008 May; 11(6):711-9. PubMed ID: 18025250
[TBL] [Abstract][Full Text] [Related]
30. Short form Conners' Adult ADHD Rating Scales: Factor structure and measurement invariance by sex in emerging adults.
Wu JS; Nankoo MMA; Bucks RS; Pestell CF
J Clin Exp Neuropsychol; 2023 May; 45(4):345-364. PubMed ID: 37610373
[TBL] [Abstract][Full Text] [Related]
31. Reliability and validity of self- and other-ratings of symptoms of ADHD in adults.
Van Voorhees EE; Hardy KK; Kollins SH
J Atten Disord; 2011 Apr; 15(3):224-34. PubMed ID: 20424007
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, placebo-controlled, multicenter study evaluating the efficacy, safety, and tolerability of extended-release metadoxine in adults with attention-deficit/hyperactivity disorder.
Manor I; Ben-Hayun R; Aharon-Peretz J; Salomy D; Weizman A; Daniely Y; Megiddo D; Newcorn JH; Biederman J; Adler LA
J Clin Psychiatry; 2012 Dec; 73(12):1517-23. PubMed ID: 23290324
[TBL] [Abstract][Full Text] [Related]
33. Psychometric properties of the Japanese version of the Adult Attention-deficit hyperactivity disorder (ADHD) Self-Report Scale (ASRS-J) and its short scale in accordance with DSM-5 diagnostic criteria.
Takeda T; Tsuji Y; Kurita H
Res Dev Disabil; 2017 Apr; 63():59-66. PubMed ID: 28260624
[TBL] [Abstract][Full Text] [Related]
34. Psychometric properties of the Wender-Reimherr Adult Attention Deficit Disorder Scale.
Marchant BK; Reimherr FW; Robison D; Robison RJ; Wender PH
Psychol Assess; 2013 Sep; 25(3):942-50. PubMed ID: 23647041
[TBL] [Abstract][Full Text] [Related]
35. Borderline personality traits and adult attention-deficit hyperactivity disorder symptoms: a genetic analysis of comorbidity.
Distel MA; Carlier A; Middeldorp CM; Derom CA; Lubke GH; Boomsma DI
Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(7):817-25. PubMed ID: 21812103
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of ADHD in adults: what is the appropriate DSM-5 symptom threshold for hyperactivity-impulsivity?
Solanto MV; Wasserstein J; Marks DJ; Mitchell KJ
J Atten Disord; 2012 Nov; 16(8):631-4. PubMed ID: 21976031
[TBL] [Abstract][Full Text] [Related]
37. Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).
Rösler M; Retz W; Thome J; Schneider M; Stieglitz RD; Falkai P
Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256 Suppl 1():i3-11. PubMed ID: 16977549
[TBL] [Abstract][Full Text] [Related]
38. Validation of the adult ADHD investigator symptom rating scale (AISRS).
Spencer TJ; Adler LA; Meihua Qiao ; Saylor KE; Brown TE; Holdnack JA; Schuh KJ; Trzepacz PT; Kelsey DK
J Atten Disord; 2010 Jul; 14(1):57-68. PubMed ID: 19794135
[TBL] [Abstract][Full Text] [Related]
39. Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate.
Rösler M; Ginsberg Y; Arngrim T; Adamou M; Niemelä A; Dejonkheere J; van Oene J; Schäuble B
World J Biol Psychiatry; 2013 May; 14(4):282-90. PubMed ID: 21517701
[TBL] [Abstract][Full Text] [Related]
40. The specificity of clinical characteristics in adults with attention-deficit/hyperactivity disorder: a comparison with patients with borderline personality disorder.
Dowson JH; McLean A; Bazanis E; Toone B; Young S; Robbins TW; Sahakian B
Eur Psychiatry; 2004 Apr; 19(2):72-8. PubMed ID: 15051105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
